NAC: 600 mg Is the Floor, Not the Target

Walk any supplement aisle and pick up an NAC bottle. The number on the front is almost always 600 mg. Occasionally 500. Occasionally 1,000. The label treats the 600 mg capsule as the standard unit, which reads as an implicit claim that 600 mg is the target dose. It is not. 600 mg is the historical starting point pulled from the mucolytic-dosing literature of the 1960s and 70s, when N-acetylcysteine was administered in three divided doses of 600 mg to thin bronchial secretions in COPD patients. That is where the number came from.

Every trial that has looked at NAC for the outcomes that actually get people to reach for it — glutathione support, liver load, PCOS, oxidative stress in trained populations, mood — has run at doses higher than 600 mg. Usually meaningfully higher. And the label almost never tells you this.

This is the same label-literacy pattern that runs through the proprietary blends problem, the electrolyte-powder sodium underdose, and the magnesium form question. The number on the front is doing work the trial dose should be doing.

What NAC Actually Does

NAC is N-acetylcysteine — an acetylated form of the amino acid cysteine. Cysteine is the rate-limiting amino acid in the synthesis of glutathione, the body's primary intracellular antioxidant. Glutathione is what your liver uses to clear reactive oxygen species, neutralize xenobiotics (including acetaminophen at overdose levels), and maintain the redox balance in every cell in the body. Cysteine intake, and cysteine bioavailability at the hepatocyte, sets the ceiling on how much glutathione the body can make.

Whole-food cysteine intake — from eggs, poultry, dairy, and cruciferous vegetables — supports baseline glutathione turnover in most people. Under conditions of increased oxidative load (chronic inflammation, high-volume training, acetaminophen exposure, PCOS, chronic viral load, aging) the demand for glutathione outstrips what dietary cysteine alone can supply. That is the case where supplemental cysteine has room to do work, and NAC is the delivery form the literature has converged on because free cysteine is unstable, poorly tolerated orally, and rapidly oxidized.

NAC works because it survives the trip to the hepatocyte, gets deacetylated to cysteine intracellularly, and feeds directly into the gamma-glutamylcysteine step of glutathione synthesis. The dose response is what you would expect for a substrate-limited reaction: below a threshold, glutathione stays flat; above a threshold, it rises; and the threshold is not 600 mg.

What the Research Actually Doses

The NAC dose-response literature spans several use cases, and each has its own trial range. None of the modern ones run at 600 mg/day.

• Chronic bronchitis / COPD mucolytic use (the historical indication): 600 mg two to three times per day, so 1,200 to 1,800 mg total. This is where the 600 mg unit came from. The clinical dosing was 600 mg three times per day, not a single 600 mg capsule.
• Glutathione support in oxidative-stress conditions: 1,200 to 1,800 mg/day in most published trials, typically split into two or three doses.
• PCOS insulin sensitivity and ovulation: 1,600 to 1,800 mg/day in the trials that have replicated the effect.
• Liver support in non-acetaminophen hepatic stress: 1,200 to 1,800 mg/day across most nutritional trials.
• Mood and OCD-spectrum use cases (obsessive-compulsive disorder, trichotillomania, skin-picking): 1,200 to 2,400 mg/day in the placebo-controlled trials that have supported the effect.
• Post-exercise oxidative-stress attenuation in trained populations: 1,200 to 1,800 mg/day in the trials that have found a signal.
• Acute acetaminophen overdose (medical use only, in-hospital): 140 mg/kg loading dose followed by 70 mg/kg every four hours for 17 doses. For a 70 kg adult that is a 9,800 mg loading dose and 4,900 mg per subsequent dose. This is not a consumer dose — it is what the emergency room administers under monitoring — but it is a data point on the upper end of the physiological tolerance range and it is worth knowing that 600 mg is nowhere near a ceiling.

The convergence point across the modern indications is 1,200 to 1,800 mg per day, split into two doses of 600 to 900 mg. A single 600 mg capsule once per day is not what any of these trials tested. It is the historical starting point, treated by most supplement bottles as the endpoint.

Why the Sulfur Smell Matters

Open a bottle of intact NAC and you get a sulfur note — sometimes described as a rotten-egg or eggy-cabbage smell. That smell is the sulfhydryl group on the cysteine, and it is the functional group that does the redox work. Intact NAC smells like sulfur. Degraded, oxidized, or old NAC smells less like sulfur, or of nothing, because the sulfhydryl has already been oxidized to a disulfide bond and the molecule can no longer donate reducing equivalents at the same rate.

A well-made NAC product has a distinct sulfur note when you open the bottle. A product that has been sitting on a warehouse shelf for two years in a permeable capsule shell, or a product that was formulated without adequate oxygen exclusion, may have already lost part of its activity. The smell is a cheap in-hand indicator of whether the molecule is intact.

Practical implication: buy from brands that turn stock quickly, store the bottle sealed and away from heat, and do not be alarmed by the sulfur smell. It is telling you the product is doing what you paid for.

Timing: With or Without Food

NAC is well absorbed either way, but the tolerability profile shifts. On an empty stomach, absorption is faster and peak plasma cysteine rises higher, which is what most of the trials use. On a full stomach, absorption is slower and the GI side effects (nausea, occasional loose stool at higher doses) drop.

The practical protocol most trials use: two doses per day, one in the morning and one in the evening, either with light food or on an empty stomach depending on tolerance. Splitting the dose matters more than the food status — a single 1,200 mg dose loads the same amount into the plasma as two 600 mg doses spaced eight hours apart, but the sustained coverage of the two-dose approach matches the timing most trials have used and the timing most consistent with the substrate-driven mechanism.

Glycine — the NAC Partner That Rarely Gets Mentioned

The glutathione synthesis pathway is gated by two rate-limiting steps: cysteine availability (the NAC step) and glycine availability (the second condensation step). In older adults, glutathione synthesis is impaired at both steps, not just the cysteine step. A more recent line of research (the "GlyNAC" approach) has combined NAC and glycine at gram-scale doses and shown restoration of glutathione turnover in older adults that neither supplement alone matches.

The doses used in the GlyNAC trials run high — around 100 mg/kg/day of each, which for a 70 kg adult is 7,000 mg per day of NAC and 7,000 mg per day of glycine. That is aggressive relative to the standard nutritional-supplement range and it was tested for short intervention windows under supervision. What it tells the general consumer is that pairing NAC with dietary or supplemental glycine (5 to 10 g/day as a starting point) makes physiological sense in populations where glutathione is genuinely stressed — older adults, chronic-disease populations, high-oxidative-load athletes. It does not mean everyone reaching for NAC needs to add glycine, but the pairing has a mechanism.

Who Should Be Cautious

NAC has a strong safety record at the doses discussed here, but a few populations warrant a conversation with a clinician before starting:

• People on nitroglycerin or other nitrates — NAC potentiates the vasodilatory effect and can produce headaches or hypotension.
• People with active bleeding disorders or on high-dose anticoagulants — NAC has mild antiplatelet activity at high doses.
• Pregnant and lactating individuals — the maternal-fetal safety data at supplemental doses is thin, and dosing decisions should sit with the obstetric team.
• Anyone with a diagnosed cystinuria — supplemental cysteine intake is contraindicated.
• Children — pediatric dosing is not equivalent to adult dosing on a mg basis and should not be extrapolated.

Nebulized NAC (a separate product from oral capsules) has been associated with paradoxical bronchospasm in a subset of asthmatic patients. This is a delivery-form issue and does not translate to the oral supplement, but it is worth noting because it comes up in the NAC-safety literature.

Reading an NAC Label

Three things to check on the bottle:

1. Milligrams per capsule and total per serving. A "600 mg NAC" bottle where the serving size is one capsule delivers 600 mg. A "1,200 mg NAC" bottle where the serving size is two capsules delivers 600 mg per capsule and 1,200 mg per serving. Do the arithmetic on the label — the front-of-bottle number is not always the per-capsule dose.

2. Form and free-cysteine claim. The label should read "N-acetyl-L-cysteine" or "N-acetylcysteine." A bottle that says only "cysteine" is not NAC and does not have the same oral bioavailability. Some newer products blend NAC with a small amount of free L-cysteine or with sustained-release excipients; the trial base is on the acetylated form alone, so the plain NAC formula is the default reference.

3. Nothing else in the capsule that shouldn't be there. A single-ingredient NAC capsule with a light excipient package (rice flour, cellulose, magnesium stearate) is what the trial literature used. A "liver support blend" or "detox complex" that lists NAC among six other ingredients is doing the same underdosing trick that runs through the proprietary blends category — you cannot tell how much NAC is actually in the bottle, and the number is usually low.

The Bottom Line

600 mg is the historical starting point, pulled from a 1960s mucolytic-dosing convention, and the modern research on the outcomes people actually buy NAC for runs at 1,200 to 1,800 mg per day. A single 600 mg capsule once daily is not the trial dose. It is the size of the historical unit multiplied by the marketing convenience of a one-capsule serving.

The label-literacy rule for NAC is the same one that applies across the underdosed corners of the supplement aisle: check the milligrams per serving against the trial range, buy the form the trials used (plain N-acetyl-L-cysteine, not a blend), trust the sulfur smell as a freshness indicator, split the dose across the day, and add glycine to the conversation if you are dosing for glutathione turnover in an older or high-oxidative-load state.

The 600 mg number on the front of the bottle is the floor. The trial dose is the target.